CD40L and Multidrug Resistance in Breast Cancer and Lymphoma
Author Information
Author(s): Voorzanger-Rousselot Nathalie, Alberti Laurent, Blay Jean-Yves
Primary Institution: Equipe Cytokines et Cancer, Unité INSERM U590, Centre Léon Bérard, Lyon, France
Hypothesis
CD40L induces multidrug resistance to apoptosis in breast carcinoma and lymphoma cells through caspase independent and dependent pathways.
Conclusion
CD40L expressed on adjacent non tumoral cells induces multidrug resistance to cytotoxic agents and ceramides in both breast carcinoma and non Hodgkin's lymphoma cell lines.
Supporting Evidence
- CD40L significantly reduced the percentage of apoptotic cells in breast carcinoma and non Hodgkin's lymphoma cell lines treated with various drugs.
- Co-culture with CD40L L cells inhibited caspase-3/7 activity in non Hodgkin's lymphoma cell lines.
- CD40L did not significantly reduce caspase-3/7 activity in breast carcinoma cell lines.
Takeaway
CD40L helps cancer cells resist treatments that usually kill them, making it harder to treat breast cancer and lymphoma.
Methodology
The study investigated the resistance induced by CD40L against apoptosis in breast carcinoma and non Hodgkin's lymphoma cell lines using various cytotoxic drugs.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website